Thursday, 21 October, 2021
E-paper

BMRC permits clinical trial of Covaxin in Bangladesh

  • Staff Correspondent
  • 4 August, 2021 12:00 AM
  • Print news
BMRC permits clinical trial of Covaxin in Bangladesh

Popular News

Covaxin, a Covid-19 vaccine produced by India’s Bharat Biotech, has received ethical permission to conduct human trial in Bangladesh.

Bangladesh Medical and Research Council (BMRC) gave the permission on July 18, said council’s chairman and former Advisor to the Prime Minister Professor Dr Syed Modasser Ali on Tuesday.

“International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), the CRO of the vaccine, sought permission for clinical trial a few months ago but we took time due to the coronavirus situation in the country,” he said.

“We have given the ethical permission for holding the clinical trial as they fulfilled all the requirements,” he said.

BMRC’s ethical permission means they (the vaccine producer) will now be able to vaccinate people if they get permission from Directorate General of Drug Administration, the BMRC chairman added.